The GLP-1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK-dependent mechanism
It has been studied for its potential benefits in neurodegenerative diseases like Alzheimer's
9b, quantification at the tumor: Fig
Muoz A, Lopez-Lopez A, Labandeira CM, Labandeira-Garcia JL (2020) Interactions between the serotonergic and other neurotransmitter systems in the basal ganglia: role in parkinsons disease and adverse effects of L-DOPA
Pan Q, Lin S, Li Y, Liu L, Li X, Gao X, et al
Among the tissues and organs crucial in regulating glucose and lipid metabolism, pancreas, brain, and adipocytes express GIP receptors (GIPRs), while pancreas, brain, and gastrointestinal tract are rich in GLP-1 receptors (GLP-1Rs) (40)